Glazer Capital LLC’s CureVac CVAC Stock Holding History

Glazer Capital LLC’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4,546,634	Closed	-$24.5M	–	372
2025 Q3	$24.5M	Buy	4,546,634 +3,951,789	+664%	+$21.4M	0.82%	24
2025 Q2	$3.23M	Buy	+594,845	New	+$2.36M	0.12%	106

Other funds holding CVAC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OBAM

ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Glazer Capital LLC's CVAC Position: Q4 2025 in Review

Glazer Capital LLC sold out of CureVac (CVAC) in Q4 2025, closing a stake of 4,546,634 shares — an estimated $24.5M sold.

Glazer Capital LLC first reported a position in CVAC in Q2 2025 and held it in 2 quarters. The position peaked at $24.5M in Q3 2025. 57 funds tracked by Wall St. Rank hold CVAC as of Q4 2025.

Glazer Capital LLC reported no remaining CureVac position as of Q4 2025 after selling out during the quarter.
Glazer Capital LLC sold 4,546,634 CureVac shares in Q4 2025, an estimated $24.5M.
Glazer Capital LLC first reported a position in CureVac in Q2 2025 and held it in 2 quarters.
Glazer Capital LLC's CureVac position peaked at $24.5M in Q3 2025.
57 funds tracked by Wall St. Rank held CureVac as of Q4 2025.

Based on Glazer Capital LLC's 13F filing for Q4 2025, filed 13 Feb 2026.